Picture of Astrana Health logo

ASTH Astrana Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Astrana Health Inc expected to post earnings of 30 cents a share - Earnings Preview

* Astrana Health Inc  ASTH.OQ   ASTH.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 7 for the
period ending March 31 2024
    * The Alhambra California-based  company is expected to
report a
22.7% increase in revenue to $413.849 million from $337.24
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Astrana Health Inc is
for
earnings of 30 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Astrana
Health
Inc is $50.00​, above​ its last closing price of $37.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.15        0.15       0.26      Beat    75.3
 Sep. 30 2023  0.31        0.33       0.47      Beat    42.4
 Jun. 30 2023  0.25        0.25       0.28      Beat    12​
 Mar. 31 2023  0.31        0.31       0.31      Met     1.1
 ​​Dec.        -0.11       -0.09      -0.06     Beat    33.3
 31 2022                                                
 Sep. 30 2022  0.31        0.32       0.56      Beat    75.8​
 Jun. 30 2022  0.20        0.20       0.25      Beat    23.2
 Mar. 31 2022  0.32        0.32       0.31      Missed  -3.1
 This summary was machine generated May 4 at 02:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Astrana Health

See all news